STRATEC SE

Declaration of Voting Results & Voting Rights Announcements • Oct 25, 2013

News Details

Voting Rights Announcements | 25 October 2013 09:38

STRATEC Biomedical AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

STRATEC Biomedical AG

25.10.2013 09:38

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---

Allianz SE, Munich, Germany, has notified us pursuant to section 21 (1)
sentence 1 in conjunction with section 24 of the German Securities Trading
Act (WpHG) on October 22, 2013 as follows:

1. Allianz Europe B.V.
   The share of voting rights held by Allianz Europe B.V., Amsterdam,
   Netherlands, in STRATEC Biomedical AG, Gewerbestr. 37, 75217 Birkenfeld,
   Germany, went above the threshold of 3% on October 20, 2013 and amounted to
   3.02% of all voting rights of the company (this reflects 354,543 of all
   11,747,745 voting rights). These voting rights are attributed to Allianz
   Europe B.V. pursuant to section 22 (1) sentence 1 number 1 of the German
   Securities Trading Act (WpHG).

The voting rights attributed to Allianz Europe B.V. were held via the
following companies controlled by Allianz Europe B.V. whose share of the
voting rights in STRATEC Biomedical AG amounted to 3% or more in each case:
Allianz Holding France SAS, Allianz France S.A., and Allianz I.A.R.D. S.A.

1. Allianz Holding France SAS
   The share of voting rights held by Allianz Holding France SAS, Paris,
   France, in STRATEC Biomedical AG, Gewerbestr. 37, 75217 Birkenfeld,
   Germany, went above the threshold of 3% on October 20, 2013 and amounted to
   3.02% of all voting rights of the company (this reflects 354,543 of all
   11,747,745 voting rights). These voting rights are attributed to Allianz
   Holding France SAS pursuant to section 22 (1) sentence 1 number 1 of the
   German Securities Trading Act (WpHG).

The voting rights attributed to Allianz Holding France SAS were held via
the following companies controlled by Allianz Holding France SAS whose
share of the voting rights in STRATEC Biomedical AG amounted to 3% or more
in each case: Allianz France S.A., and Allianz I.A.R.D. S.A.

1. Allianz France S.A.
   The share of voting rights held by Allianz France S.A., Paris, France, in
   STRATEC Biomedical AG, Gewerbestr. 37, 75217 Birkenfeld, Germany, went
   above the threshold of 3% on October 20, 2013 and amounted to 3.02% of all
   voting rights of the company (this reflects 354,543 of all 11,747,745
   voting rights). These voting rights are attributed to Allianz France S.A.
   pursuant to section 22 (1) sentence 1 number 1 of the German Securities
   Trading Act (WpHG).

The voting rights attributed to Allianz France S.A. were held via the
following companies controlled by Allianz France S.A. whose share of the
voting rights in STRATEC Biomedical AG amounted to 3% or more in each case:
Allianz I.A.R.D. S.A.

1. Allianz I.A.R.D. S.A.
   The share of voting rights held by Allianz I.A.R.D. S.A., Paris, France, in
   STRATEC Biomedical AG, Gewerbestr. 37, 75217 Birkenfeld, Germany, went
   above the threshold of 3% on October 20, 2013 and amounted to 3.02% of all
   voting rights of the company (this reflects 354,543 of all 11,747,745
   voting rights).

25.10.2013 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---

Language: English
Company: STRATEC Biomedical AG
Gewerbestr. 37
75217 Birkenfeld
Germany
Internet: www.stratec.com

End of Announcement DGAP News-Service

---